Capital Fund Management S.A. Seagen Inc. Transaction History

Capital Fund Management S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$117.37 - $139.17 $8.41 Million - $9.97 Million	71,646 New	71,646 $9.21 Million
Q2 2021 Aug 12, 2021	SELL	$135.08 - $161.1 $8.51 Million - $10.1 Million	-62,994 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$137.51 - $190.8 $6.47 Million - $8.98 Million	47,075 Added 295.72%	62,994 $8.75 Million
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $2.62 Million - $3.37 Million	15,919 New	15,919 $2.79 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.